Brief: Tcr Therapeutics Presents Preclinical Data On Functional Activity Of Gavo-Cel
07/11/2022 13:17
Nov 7 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS PRESENTS PRECLINICAL DATA ON FUNCTIONAL
ACTIVITY OF GAVO-CEL AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER
Source text for Eikon: ID:nGNX4lvC6t
Further company coverage: TCRR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview